RA therapy with exosomes from MSC enriched with circFBXW7 can significantly suppress the inflammatory response of RA-FLS by absorbing miR-216a-3p, which releases histone deacetylase-4 activation, playing an inhibitory role in the RA inflammation progression [239]. Here, HDAC4 is linked to rheumatoid arthritis.